That was less impressive than the comps reported by Rite Aid's larger rivals Walgreen (nyse: WAG - news - people ), which clocked in at 10.8%, and CVS (nyse: CVS - news - people ), which racked up a 7.1% gain.

FORBES: Rite Aid Gets Some Relief